ArticleTrials2021

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.

Benjamin Gaborit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.